To realise the full potential for biosimilars, stakeholders must build a better understanding of biosimilars and to take a comprehensive view of how these important medicines can fit into treatment pathways.
Virginia Acha
Advertisement
Virginia Acha, DPhil, is director of regulatory policy, Europe, Middle East and Africa, at Amgen.
Articles by Virginia Acha
Advertisement
Latest Updated Articles
Emerging Opportunities with BiosimilarsPublished: August 1st 2014 | Updated:
Advertisement
Advertisement
